Ahmad Muhammad, Tahir Maleha, Hong Zibin, Zia Muhammad Anjum, Rafeeq Hamza, Ahmad Muhammad Shaheez, Rehman Saif Ur, Sun Junming
Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital-Ganzhou Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Institute of Physiology and Pharmacology, Faculty of Veterinary Science, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Front Pharmacol. 2025 Jan 6;15:1497668. doi: 10.3389/fphar.2024.1497668. eCollection 2024.
Plant- and marine-derived natural products are rich sources of bioactive compounds essential for drug discovery. These compounds contain complex mixtures of metabolites, which collectively contribute to their pharmacological properties. However, challenges arise in the isolation of individual bioactive compounds, owing to their intricate chemistry and low abundance in natural extracts. Despite these limitations, numerous plant and marine-derived compounds have achieved regulatory approval, particularly for treating cancer and infectious diseases. This review explores the therapeutic potential of plant and marine sources along with innovative extraction and isolation methods that support sustainable drug development. Future perspectives will highlight the role of responsible innovation, artificial intelligence, and machine learning in advancing drug discovery, underscoring the importance of continued research to meet global health needs.
植物和海洋来源的天然产物是药物发现所需生物活性化合物的丰富来源。这些化合物含有复杂的代谢物混合物,共同构成了它们的药理特性。然而,由于其复杂的化学结构和在天然提取物中的低丰度,分离单个生物活性化合物面临挑战。尽管存在这些限制,但许多植物和海洋来源的化合物已获得监管批准,特别是用于治疗癌症和传染病。本综述探讨了植物和海洋来源的治疗潜力以及支持可持续药物开发的创新提取和分离方法。未来展望将强调负责任的创新、人工智能和机器学习在推进药物发现中的作用,强调持续研究以满足全球健康需求的重要性。